631
Participants
Start Date
July 1, 2011
Primary Completion Date
April 5, 2012
Study Completion Date
April 5, 2012
Evolocumab
Administered by subcutaneous injection
Placebo to Evolocumab
Administered by subcutaneous injection
Research Site, Budapest
Research Site, Dunaújváros
Research Site, Ballerup Municipality
Research Site, Komárom
Research Site, Eger
Research Site, Debrecen
Research Site, Szolnok
Research Site, Gyula
Research Site, Kecskemét
Research Site, Vejle
Research Site, Zalaegerszeg
Research Site, Aalborg
Research Site, Mosonmagyaróvár
Research Site, Cortlandt Manor
Research Site, Williamsville
Research Site, Pittsburgh
Research Site, Camp Hill
Research Site, York
Research Site, Philadelphia
Research Site, Winston-Salem
Research Site, Smithfield
Research Site, Spartanburg
Research Site, Florence
Research Site, Green Cove Springs
Research Site, Daytona Beach
Research Site, Melbourne
Research Site, Miami
Research Site, Miami
Research Site, Port Charlotte
Research Site, Birmingham
Research Site, Jackson
Research Site, Jackson
Research Site, Tupelo
Research Site, Lexington
Research Site, Marion
Research Site, Canton
Research Site, Sandusky
Research Site, Mansfield
Research Site, Cincinnati
Research Site, Cincinnati
Research Site, Dayton
Research Site, Indianapolis
Research Site, Hammond
Research Site, Valparaiso
Research Site, Ypsilanti
Research Site, Kalamazoo
Research Site, Marquette
Research Site, Iowa City
Research Site, Madison
Research Site, Rapid City
Research Site, Great Falls
Research Site, Peoria
Research Site, Malvern
Research Site, Houston
Research Site, Houston
Research Site, Littleton
Research Site, Colorado Springs
Research Site, Tucson
Research Site, Westlake Village
Research Site, Newport Beach
Research Site, Anaheim
Research Site, Carmichael
Research Site, Roseville
Research Site, Tacoma
Research Site, Auburn
Research Site, Bangor
Research Site, Portland
Research Site, Voorhees Township
Research Site, Burnaby
Research Site, Kelowna
Research Site, Vancouver
Research Site, Victoria
Research Site, Cambridge
Research Site, Greater Sudbury
Research Site, Hamilton
Research Site, London
Research Site, London
Research Site, Newmarket
Research Site, Oshawa
Research Site, Oshawa
Research Site, Sarnia
Research Site, Scarborough Village
Research Site, Toronto
Research Site, Toronto
Research Site, Woodstock
Research Site, Gatineau
Research Site, Lachine
Research Site, Longueuil
Research Site, Pointe-Claire
Research Site, Québec
Research Site, Brno
Research Site, Brno
Research Site, Brno
Research Site, Olomouc
Research Site, Prague
Research Site, Prague
Research Site, Slaný
Research Site, Svitavy
Research Site, Ústí nad Orlicí
Research Site, Znojmo
Lead Sponsor
The TIMI Study Group
OTHER
Amgen
INDUSTRY